James P. Allison

Specialty: CTLA-4 Immunotherapy

Location: Unknown

Tier: ELITE

H-Index: 185

Years Active: 0

Hospital Affiliations

• MD Anderson Cancer Center - Faculty

Key Publications

1. "Immune checkpoint therapy-current perspectives and future directions." - Cell (2023)
2. "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response." - Science (2021)
3. "Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy." - Nature (2025)
4. "The future of immune checkpoint therapy." - Science (2015)
5. "Fundamental Mechanisms of Immune Checkpoint Blockade Therapy." - Cancer Discov (2018)

Knowledge Graph Relationships

James P. Allison is a CTLA-4 Immunotherapy specialist affiliated with MD Anderson Cancer Center. Authored 5 scholarly articles.